Status: current, Primitive. Date: 30-Jun 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4133831000168112 | Ogen 625 microgram tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4133841000168115 | Ogen (oestrone sulfate sodium (as piperazine sulfate) 625 microgram) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ogen 625 microgram tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Ogen 625 microgram tablet | has intended active ingredient | oestrone sulfate sodium | true | Inferred relationship | Some | 1898304896 | |
| Ogen 625 microgram tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ogen 625 microgram tablet | Is a | Ogen | true | Inferred relationship | Some | ||
| Ogen 625 microgram tablet | Is a | oestrone sulfate sodium 625 microgram tablet | true | Inferred relationship | Some | ||
| Ogen 625 microgram tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Ogen 625 microgram tablet | has Australian BoSS | oestrone sulfate sodium | true | Inferred relationship | Some | 1898304896 | |
| Ogen 625 microgram tablet | has unit of use | tablet | true | Inferred relationship | Some | 1898304897 |
Reference Sets
Trade product unit of use reference set
FHIR